Format

Send to

Choose Destination
Br J Clin Pharmacol. 2007 Jul;64(1):100-4. Epub 2007 Feb 12.

Trends over 5 years in cardiovascular medicine use in Australian veterans with diabetes.

Author information

1
Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute, University of South Australia, Adelaide, Australia. libby.roughead@unisa.edu.au

Abstract

AIM:

To determine trends over 5 years in cardiovascular medicine use in the Australian veteran population with diabetes.

METHODS:

An observational study. All veterans dispensed medicines indicative of diabetes between 2000 and 2005 were identified from the Veterans Affairs pharmacy claims dataset. Concurrent dispensings of angiotensin-converting enzyme inhibitor (ACEI), lipid-lowering medicines and antiplatelets were assessed.

RESULTS:

ACEI/angiotensin II receptor blocker use has risen from 46% to 67% in the veteran population dispensed medicines indicative of diabetes. Lipid-lowering medicines have increased from 33% to 58% and antiplatelets from 28% to 50%.

CONCLUSION:

The increasing use of cardiovascular medicines in the diabetes population is suggestive of improved treatment practices over time, consistent with guidelines and quality use of medicines initiatives.

PMID:
17298476
PMCID:
PMC2000620
DOI:
10.1111/j.1365-2125.2007.02853.x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center